BioNexus Gene Lab Corp. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
BioNexus Gene Lab Corp. (BGLC) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of -$459.64 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-15.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2024-11-15
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-09-30 was -$176.26K.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-06-30 was -$72.04K.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-03-31 was -$211.34K.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-12-31 was $708.00, a 60.62% decline year-over-year.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was $0.00.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was -$6.39K.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2020 was -$34.92K.
- BioNexus Gene Lab Corp. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2019 was $0.00.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | -$176.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$248.30K derived: sum of 2 quarters · filed 2024-11-15 | -$459.64K 10-Q · filed 2024-11-15 | -$458.93K derived: sum of 4 quarters · filed 2024-11-15 | |
| 2024-06-30 | -$72.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$283.38K 10-Q · filed 2024-08-14 | -$282.67K derived: sum of 3 quarters · filed 2024-11-15 | -$309.53K derived: sum of 4 quarters · filed 2024-11-15 | |
| 2024-03-31 | -$211.34K 10-Q · filed 2024-05-15 | -$210.64K derived: sum of 2 quarters · filed 2024-11-15 | -$237.49K derived: sum of 3 quarters · filed 2024-11-15 | -$237.49K derived: sum of 4 quarters · filed 2024-11-15 | |
| 2023-12-31 | $708.00 derived: 10-Q 12 month − 10-Q/A 9 month · filed 2024-11-15 | -$26.15K derived: sum of 2 quarters · filed 2024-11-15 | -$26.15K derived: sum of 3 quarters · filed 2024-11-15 | -$26.15K 10-Q · filed 2024-11-15 | |
| 2023-09-30 | -$26.85K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | -$26.85K derived: sum of 2 quarters · filed 2024-03-26 | -$26.85K 10-Q/A · filed 2024-03-26 | -$25.06K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $0.00 10-Q · filed 2023-08-16 | $1.80K derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $1.80K derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 | |
| 2022-12-31 | $1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 | -$1.78K 10-Q · filed 2023-05-09 |
| 2022-09-30 | -$1.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.80K derived: sum of 2 quarters · filed 2022-11-14 | -$1.80K 10-Q · filed 2022-11-14 | -$1.78K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $22.00 derived: sum of 3 quarters · filed 2023-03-31 | $74.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $22.00 derived: sum of 2 quarters · filed 2023-03-31 | $74.00 derived: sum of 3 quarters · filed 2023-03-31 | -$6.39K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $22.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $74.00 derived: sum of 2 quarters · filed 2023-03-31 | -$6.39K derived: sum of 3 quarters · filed 2023-03-31 | -$6.39K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $52.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$6.41K derived: sum of 2 quarters · filed 2021-11-15 | -$6.41K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$6.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$6.47K 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-18 | ||||
| 2020-12-31 | -$34.92K 10-K · filed 2022-04-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |